256 related articles for article (PubMed ID: 24261363)
41. Positron-emission tomography and computed tomography of cystic pancreatic masses.
Tann M; Sandrasegaran K; Jennings SG; Skandarajah A; McHenry L; Schmidt CM
Clin Radiol; 2007 Aug; 62(8):745-51. PubMed ID: 17604762
[TBL] [Abstract][Full Text] [Related]
42. Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions.
Maurea S; Mainolfi C; Bazzicalupo L; Panico MR; Imparato C; Alfano B; Ziviello M; Salvatore M
AJR Am J Roentgenol; 1999 Jul; 173(1):25-9. PubMed ID: 10397094
[TBL] [Abstract][Full Text] [Related]
43. Comparison of delayed enhanced CT and 18F-FDG PET/CT in the evaluation of adrenal masses in oncology patients.
Park BK; Kim CK; Kim B; Choi JY
J Comput Assist Tomogr; 2007; 31(4):550-6. PubMed ID: 17882030
[TBL] [Abstract][Full Text] [Related]
44. The indeterminate adrenal lesion.
Sahdev A; Willatt J; Francis IR; Reznek RH
Cancer Imaging; 2010 Mar; 10(1):102-13. PubMed ID: 20299300
[TBL] [Abstract][Full Text] [Related]
45. Distinguishing adrenal adenomas from nonadenomas: combined use of diagnostic parameters of unenhanced and short 5-minute dynamic enhanced CT protocol.
Kamiyama T; Fukukura Y; Yoneyama T; Takumi K; Nakajo M
Radiology; 2009 Feb; 250(2):474-81. PubMed ID: 19037020
[TBL] [Abstract][Full Text] [Related]
46. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
47. Is sonographic flow imaging useful in the differential diagnosis of adrenal masses?
Ghiatas AA; Chopra S; Schnitker JB
Br J Radiol; 1996 Nov; 69(827):1005-8. PubMed ID: 8958016
[TBL] [Abstract][Full Text] [Related]
48. Role of baseline nodule density and changes in density and nodule features in the discrimination between benign and malignant solid indeterminate pulmonary nodules.
Xu DM; van Klaveren RJ; de Bock GH; Leusveld AL; Dorrius MD; Zhao Y; Wang Y; de Koning HJ; Scholten ET; Verschakelen J; Prokop M; Oudkerk M
Eur J Radiol; 2009 Jun; 70(3):492-8. PubMed ID: 18417311
[TBL] [Abstract][Full Text] [Related]
49. Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography/computed tomography: a review of literature.
Kandathil A; Wong KK; Wale DJ; Zatelli MC; Maffione AM; Gross MD; Rubello D
Endocrine; 2015 May; 49(1):6-26. PubMed ID: 25273320
[TBL] [Abstract][Full Text] [Related]
50. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of adrenal masses with gadolinium enhancement and fat-suppressed MR imaging.
Semelka RC; Shoenut JP; Lawrence PH; Greenberg HM; Maycher B; Madden TP; Kroeker MA
J Magn Reson Imaging; 1993; 3(2):337-43. PubMed ID: 8448395
[TBL] [Abstract][Full Text] [Related]
52. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT.
Caoili EM; Korobkin M; Francis IR; Cohan RH; Platt JF; Dunnick NR; Raghupathi KI
Radiology; 2002 Mar; 222(3):629-33. PubMed ID: 11867777
[TBL] [Abstract][Full Text] [Related]
53. Analysis of adrenal masses by 18F-FDG positron emission tomography scanning.
Han SJ; Kim TS; Jeon SW; Jeong SJ; Yun M; Rhee Y; Kang ES; Cha BS; Lee EJ; Lee HC; Lim SK
Int J Clin Pract; 2007 May; 61(5):802-9. PubMed ID: 17343665
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT.
Satoh Y; Ichikawa T; Motosugi U; Kimura K; Sou H; Sano K; Araki T
AJR Am J Roentgenol; 2011 Feb; 196(2):447-53. PubMed ID: 21257899
[TBL] [Abstract][Full Text] [Related]
55. Adrenal masses of varied etiology: anatomical and molecular imaging features on PET-CT.
Sharma P; Singh H; Dhull VS; Suman KC S; Kumar A; Bal C; Kumar R
Clin Nucl Med; 2014 Mar; 39(3):251-60. PubMed ID: 24217551
[TBL] [Abstract][Full Text] [Related]
56. Contemporary imaging of incidentally discovered adrenal masses.
Wale DJ; Wong KK; Viglianti BL; Rubello D; Gross MD
Biomed Pharmacother; 2017 Mar; 87():256-262. PubMed ID: 28063406
[TBL] [Abstract][Full Text] [Related]
57. Texture Analysis as a Radiomic Marker for Differentiating Benign From Malignant Adrenal Tumors.
Yu H; Parakh A; Blake M; McDermott S
J Comput Assist Tomogr; 2020; 44(5):766-771. PubMed ID: 32842071
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.
Erasmus JJ; Patz EF; McAdams HP; Murray JG; Herndon J; Coleman RE; Goodman PC
AJR Am J Roentgenol; 1997 May; 168(5):1357-60. PubMed ID: 9129444
[TBL] [Abstract][Full Text] [Related]
59. Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT?
Schaarschmidt BM; Grueneisen J; Heusch P; Gomez B; Umutlu L; Ruhlmann V; Rosenbaum-Krumme S; Antoch G; Buchbender C
Nucl Med Commun; 2015 Jun; 36(6):588-95. PubMed ID: 25759944
[TBL] [Abstract][Full Text] [Related]
60. Can Adrenal Adenomas Be Differentiated From Adrenal Metastases at Single-Phase Contrast-Enhanced CT?
Tu W; Verma R; Krishna S; McInnes MDF; Flood TA; Schieda N
AJR Am J Roentgenol; 2018 Nov; 211(5):1044-1050. PubMed ID: 30207794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
